About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Mucinex Exploratory Cold Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT01046136

Mucinex Exploratory Cold Study

This is an exploratory, multicenter, randomized, blinded, placebo-controlled study of Mucinex in patients with colds. Patients will receive 7 days of treatment with either Mucinex or placebo. The stud...

Lead sponsor: Reckitt Benckiser Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Reckitt Benckiser Inc.

Age

12 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•common cold symptoms
•meet symptom severity
•females of child-bearing potential must have negative pregnancy test and use effective birth control

Exclusion Criteria

•chronic respiratory conditions
•significant heart, kidney, liver, or lung disease, uncontrolled hypertension or diabetes, cystic fibrosis, thyroid disorder
•pregnant or lactating
•known malignancy
•participation in any other clinical trial within 30 days of baseline
•related to another enrolled patient or persons involved directly or indirectly with the conduct of this study

Related studies

RECRUITINGPhase 3

Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine

NCT06531707 · Common Cold

COMPLETEDPhase 4

A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin

NCT06716645 · Common Cold, Cough

COMPLETEDPhase 4

Otrivine: Quality of Life (QoL) Impact in a Real-World Setting

NCT05556148 · Common Cold

Commercially Available Cannabis Products for Immune Support

NCT05944705 · Influenza, COVID-19, and more

COMPLETEDPhase 3

Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold

NCT01361399 · Common Cold, Pharyngitis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 30, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment378

Start dateDec 2009

Last updatedDec 30, 2020

Condition

Locations shown

Pioneer Clinical Research

Bellevue, Nebraska

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 30, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions